Hutch News

Hutch News

Stories tagged 'Vaccine and Infectious Disease'

First human antibody found to block Epstein-Barr virus

Early research could open new path for vaccine against EBV-related cancers, mononucleosis

April 17, 2018 | By Mary Engel / Fred Hutch News Service

The finding opens a new path to developing a vaccine against EBV, a virus best known for causing mono but which is associated with about 200,000 cancer cases a year.

View story >


With approval of new CMV drug for transplant patients, a legacy continues

Tissue samples from a clinical trial conducted decades ago yield new insights and treatments

April 12, 2018 | By Mary Engel / Fred Hutch News Service

Tissue samples from a landmark clinical trial conducted decades ago by the late Dr. Joel Meyers yield new insights and treatments

View story >


Scientists-turned-entrepreneurs share lessons learned launching startups

From venture capital to office space to acquisitions, academics starting companies face a steep learning curve — but there’s help to be found

March 26, 2018 | By Rachel Tompa / Fred Hutch News Service

Scientists who make the leap from academia to founding their own companies face a steep learning curve. There's a lot to learn and a lot to take in. But help is available.

View story >


New antibody and unique binding site offer possible paths to malaria prevention

Led by NIH, Fred Hutch researchers, early study holds promise for direct infusion or vaccine design

March 19, 2018 | By Mary Engel / Fred Hutch News Service

Fred Hutch structural biologist Dr. Marie Pancera is seeking clues for designing a malaria vaccine by studying the differences between newly discovered antibodies that bind the same site on the malaria parasite.

View story >


Jump-starting innovative projects exploring pathogen-associated cancers

Pathogen-Associated Malignancies Integrated Research Center awards first round of pilot funding supporting researchers studying H. pylori, EBV and the microbiome

March 16, 2018 | By Sabrina Richards

Announcing the inaugural recipients of the PAM IRC Innovation Awards for innovative projects exploring pathogens associated with cancer.

View story >


Meet Global Oncology's deputy program head

Key early experiences shaped Dr. Thomas Uldrick's path toward HIV-associated cancers, global health

Feb. 22, 2018 | By Mary Engel / Fred Hutch News Service

Dr. Thomas Uldrick brings expertise in HIV-related cancers and experience in — and a passion for — developing clinical trials to his new position at Fred Hutch Global Oncology.

View story >



(RSS feeds are best viewed in browsers other than Chrome)

Editor's Picks

GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Magazine Archive
Back issues of Hutch Magazine

Financial Reporting
Fiscal highlights & Annual Reports

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.